
ChIP-seq
End-to-end ChIP-seq Services
- Full project: From chromatin preparation through analysis
- Library QC metrics and sequencing-ready material or FASTQ delivery
- Detailed report with QC, peak calls, and biological insights
Epigenome Technologies delivers single-cell CUT&Tag programs that profile histone modifications, transcription factors, and chromatin-associated proteins in heterogeneous populations without flow sorting. We qualify antibodies, optimize nuclei handling, and return interpretable cell-by-peak matrices that integrate directly with your scRNA-seq pipelines.
Targeted Chromatin Profiling
Precise protein–DNA mapping
Antibody-Driven Assay Design
Optimized for each target
Built for Cellular Resolution
Cell-state–specific insight
Single-cell CUT&Tag uses antibody-targeted tagmentation to map where histone modifications, transcription factors, or chromatin-associated proteins bind DNA across individual cells. The approach delivers fragment-level precision for regulatory element annotation, heterogeneity discovery, and rare-cell epigenetic characterization without flow cytometry pre-enrichment.
| Platform | Cat. No. | Best For | Typical Cell Count |
|---|---|---|---|
| Droplet scCUT&Tag | SCTDS201 | 10x Genomics-compatible workflows; integrated multiome readouts | 5,000–10,000 cells/sample |
| BD Rhapsody compatible scCUT&Tag | SCTBS201 | BD Rhapsody-compatible workflows; high cel recovery | 30,000–80,000 cells/sample |
| Emulsion scCUT&Tag | SCTDE201 | High-throughput cohorts; flexible cell input and antibody panels | 10,000–50,000 cells/sample |
Integrates with 10x Genomics platforms for straightforward scRNA-seq + epigenetic multiome workflows. Ideal when combining transcript and histone modification profiles in the same cells.
High-throughput emulsion chemistry for large-scale profiling or when 10x compatibility is not required. Flexible antibody panels and cell counts support discovery-phase heterogeneity studies.
We confirm target antibodies, cell counts, and nuclei handling protocols; optional antibody validation runs ensure signal quality before full cohort commitment.
Nuclei isolation, antibody staining, and droplet or emulsion encapsulation with QC on viability, tagmentation efficiency, and fragment distribution.
Paired-end runs on NovaSeq or NextSeq platforms with depth monitoring against internal signal-to-noise benchmarks.
Automated cell calling, peak annotation, and cell-type clustering with data packages aligned to your preferred analysis environment.
Share your target antibodies, cohort size, and required timelines. We will return a scoped scCUT&Tag brief outlining platform selection, antibody validation strategy, QC checkpoints, and downstream reporting.